The fact they state
"assess its registration options"
for an eligible CBD product, including a formulation of its current LGP Classic CBD50 and LGP Classic 1:100 cannabis oil medicines.
rather than something like "commit to a study ASAP"
Makes me wonder if they're hoping there's some pathway to registration that is not a costly/time consuming efficacy study.
Given that OTC CBD has come about because of the known efficacy and very low risk... I wonder if there isn't a streamlined registration in the pipeline.
LGP - best in class, page-147
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
